MYC and follicular lymphoma: The dysregulation of these oncogenes drives B-cell hematological malignancies such as follicular lymphoma (BCL2 translocation, MLL2 inactivation) (11, 67) DLBCL (e.g. BCL6, BCL2 and MYC translocation) (8, 68, 69) or Burkitt’s lymphoma (MYC translocation) (70, 71).